Showing 1,141 - 1,160 results of 59,430 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((nn decrease) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 1141
  2. 1142

    A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension by Hiroshi Saga (584103)

    Published 2014
    “…To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 <i>in vivo</i>. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.…”
  3. 1143
  4. 1144
  5. 1145
  6. 1146

    Dual-task costs (as a percentage decrease in performance compared to single-task performance) (mean ± standard error of the mean), * <i>p</i> < .05, ** <i>p</i> < .01. by Toby J. Ellmers (3337116)

    Published 2016
    “…<p>Dual-task costs (as a percentage decrease in performance compared to single-task performance) (mean ± standard error of the mean), * <i>p</i> < .05, ** <i>p</i> < .01.…”
  7. 1147
  8. 1148
  9. 1149
  10. 1150
  11. 1151
  12. 1152
  13. 1153
  14. 1154
  15. 1155
  16. 1156
  17. 1157

    A flow diagram of the study entry. by Sakiko Fukui (387048)

    Published 2025
    “…Cluster analysis classified 4 clusters of decline in food intake changes during the last 6 months before death: immediate decrease (n = 14); decrease from 1 month before death (n = 24); decrease from 3 months before death (n = 7); and gradual decrease for 6 months before death (n = 24).…”
  18. 1158

    Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia by Mary E. Irwin (293687)

    Published 2013
    “…In two human Ph+ALL cell lines, inhibition of ErbB kinase activity with canertinib resulted in a dose-dependent decrease in the phosphorylation of an ErbB kinase signaling target p70S6-kinase T389 (by 60% in Z119 and 39% in Z181 cells at 3 µM). …”
  19. 1159
  20. 1160